Dr. rer. nat. Gita Naseri
Profil
Zusammenfassung
Dr. Naseri entwickelt Methoden zur präzisen Steuerung von Genexpression in Hefezellen, um diese als Biofabriken für die nachhaltige Herstellung von Naturstoffen und Spezialchemikalien zu nutzen. Sie kombiniert synthetische Biologie mit Optimierungsstrategien, um komplexe biosynthetische Stoffwechselwege in Mikroorganismen zu konstruieren und zu balancieren. Ihre Expertise liegt in der Etablierung orthogonaler Regulationssysteme und hochdurchsatzgestützten Methoden für die kombinatorische Optimierung von Genen und Stoffwechselwegen.
Skills
Stammdaten
Identität, Organisation und Kontakt aus HU-FIS.
Forschungsthemen2
Eine umfassende Plattform für die nachhaltige Biosynthese von seltenen Naturstoffen in Pichia pastoris
Quelle ↗Förderer: DFG Nachwuchsgruppe Zeitraum: 04/2024 - 03/2027 Projektleitung: Dr. rer. nat. Gita Naseri
Eine umfassende Plattform für die nachhaltige Biosynthese von seltenen Naturstoffen in Pichia pastoris
Quelle ↗Förderer: DFG Nachwuchsgruppe Zeitraum: 04/2024 - 03/2030 Projektleitung: Dr. rer. nat. Gita Naseri
Mögliche Industrie-Partner109
Details nur für eingeloggte sichtbar
🔒 Das System hat 109 mögliche Industrie-Partner gefunden — Firmen, Scores und Begründungen sind nur für eingeloggte Nutzer:innen sichtbar. Anmelden
Publikationen20
Top 25 nach Zitationen — Quelle: OpenAlex (BAAI/bge-m3 embedded für Matching).
Nature Communications · 179 Zitationen · DOI
In the first wave of synthetic biology, genetic elements, combined into simple circuits, are used to control individual cellular functions. In the second wave of synthetic biology, the simple circuits, combined into complex circuits, form systems-level functions. However, efforts to construct complex circuits are often impeded by our limited knowledge of the optimal combination of individual circuits. For example, a fundamental question in most metabolic engineering projects is the optimal level of enzymes for maximizing the output. To address this point, combinatorial optimization approaches have been established, allowing automatic optimization without prior knowledge of the best combination of expression levels of individual genes. This review focuses on current combinatorial optimization methods and emerging technologies facilitating their applications.
ACS Synthetic Biology · 53 Zitationen · DOI
Control of gene expression by transcription factors (TFs) is central in many synthetic biology projects for which a tailored expression of one or multiple genes is often needed. As TFs from evolutionary distant organisms are unlikely to affect gene expression in a host of choice, they represent excellent candidates for establishing orthogonal control systems. To establish orthogonal regulators for use in yeast (Saccharomyces cerevisiae), we chose TFs from the plant Arabidopsis thaliana. We established a library of 106 different combinations of chromosomally integrated TFs, activation domains (yeast GAL4 AD, herpes simplex virus VP64, and plant EDLL) and synthetic promoters harboring cognate cis-regulatory motifs driving a yEGFP reporter. Transcriptional output of the different driver/reporter combinations varied over a wide spectrum, with EDLL being a considerably stronger transcription activation domain in yeast than the GAL4 activation domain, in particular when fused to Arabidopsis NAC TFs. Notably, the strength of several NAC-EDLL fusions exceeded that of the strong yeast TDH3 promoter by 6- to 10-fold. We furthermore show that plant TFs can be used to build regulatory systems encoded by centromeric or episomal plasmids. Our library of TF-DNA binding site combinations offers an excellent tool for diverse synthetic biology applications in yeast.
Nature Communications · 51 Zitationen · DOI
Balanced expression of multiple genes is central for establishing new biosynthetic pathways or multiprotein cellular complexes. Methods for efficient combinatorial assembly of regulatory sequences (promoters) and protein coding sequences are therefore highly wanted. Here, we report a high-throughput cloning method, called COMPASS for COMbinatorial Pathway ASSembly, for the balanced expression of multiple genes in Saccharomyces cerevisiae. COMPASS employs orthogonal, plant-derived artificial transcription factors (ATFs) and homologous recombination-based cloning for the generation of thousands of individual DNA constructs in parallel. The method relies on a positive selection of correctly assembled pathway variants from both, in vivo and in vitro cloning procedures. To decrease the turnaround time in genomic engineering, COMPASS is equipped with multi-locus CRISPR/Cas9-mediated modification capacity. We demonstrate the application of COMPASS by generating cell libraries producing β-carotene and co-producing β-ionone and biosensor-responsive naringenin. COMPASS will have many applications in synthetic biology projects that require gene expression balancing.
Kooperationen0
Bestätigte Forscher↔Partner-Paare aus HU-FIS — Gold-Standard-Positive für das Matching.
Aus HU-FIS sind keine Kooperationen für diese Person gemeldet.